These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25527102)

  • 1. Primary prevention of atherosclerotic cardiovascular disease: controversies and clinical considerations.
    Newsom LC
    Ann Pharmacother; 2015 Apr; 49(4):484-93. PubMed ID: 25527102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
    Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
    Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA).
    Yeboah J; Sillau S; Delaney JC; Blaha MJ; Michos ED; Young R; Qureshi WT; McClelland R; Burke GL; Psaty BM; Herrington DM
    Am Heart J; 2015 Mar; 169(3):387-395.e3. PubMed ID: 25728729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
    Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
    Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide.
    Pokharel Y; Tang F; Jones PG; Nambi V; Bittner VA; Hira RS; Nasir K; Chan PS; Maddox TM; Oetgen WJ; Heidenreich PA; Borden WB; Spertus JA; Petersen LA; Ballantyne CM; Virani SS
    JAMA Cardiol; 2017 Apr; 2(4):361-369. PubMed ID: 28249067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Statin Prescribing for Secondary Prevention in Primary Care Following New Guideline Recommendations.
    Zupec JF; Marrs JC; Saseen JJ
    Ann Pharmacother; 2016 Jan; 50(1):17-21. PubMed ID: 26416950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Controversies With Recent Cholesterol Treatment Guidelines.
    Phillips E; Saseen JJ
    J Pharm Pract; 2016 Feb; 29(1):15-25. PubMed ID: 26611871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of statin assignment using the 2013 AHA/ACC Cholesterol Guideline versus the 2001 NCEP ATP III guideline: correlation with atherosclerotic plaque imaging.
    Johnson KM; Dowe DA
    J Am Coll Cardiol; 2014 Sep; 64(9):910-9. PubMed ID: 25169177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacist understanding of the 2013 American College of Cardiology/American Heart Association cholesterol guideline.
    Bucheit JD; Helsing H; Nadpara P; Virani SS; Dixon DL
    J Clin Lipidol; 2018; 12(2):367-374.e3. PubMed ID: 29277495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy.
    Mortensen MB; Afzal S; Nordestgaard BG; Falk E
    J Am Coll Cardiol; 2015 Dec; 66(24):2699-2709. PubMed ID: 26700832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of the American College of Cardiology/American Heart Association guidelines for the treatment of blood cholesterol for a rural community: Data from the Heart of New Ulm Project.
    Miedema MD; Sidebottom AC; Sillah A; Benson G; Knickelbine T; VanWormer JJ
    J Clin Lipidol; 2017; 11(1):94-101. PubMed ID: 28391916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol treatment and changes in guidelines in an academic medical practice.
    Schoen MW; Salas J; Scherrer JF; Buckhold FR
    Am J Med; 2015 Apr; 128(4):403-9. PubMed ID: 25460526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gaps.
    Lopez-Jimenez F; Simha V; Thomas RJ; Allison TG; Basu A; Fernandes R; Hurst RT; Kopecky SL; Kullo IJ; Mulvagh SL; Thompson WG; Trejo-Gutierrez JF; Wright RS
    Mayo Clin Proc; 2014 Sep; 89(9):1257-78. PubMed ID: 25131697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2018 Cholesterol Clinical Practice Guidelines: Synopsis of the 2018 American Heart Association/American College of Cardiology/Multisociety Cholesterol Guideline.
    Grundy SM; Stone NJ;
    Ann Intern Med; 2019 Jun; 170(11):779-783. PubMed ID: 31132793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin Use in the U.S. for Secondary Prevention of Cardiovascular Disease Remains Suboptimal.
    Ngo-Metzger Q; Zuvekas S; Shafer P; Tracer H; Borsky AE; Bierman AS
    J Am Board Fam Med; 2019; 32(6):807-817. PubMed ID: 31704749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals.
    Egan BM; Li J; White K; Fleming DO; Connell K; Hernandez GT; Jones DW; Ferdinand KC; Sinopoli A
    J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27543306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study.
    Yang Q; Zhong Y; Gillespie C; Merritt R; Bowman B; George MG; Flanders WD
    BMJ Open; 2017 Jan; 7(1):e011684. PubMed ID: 28119384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerotic cardiovascular disease risk assessment and predictors of statin use in Filipino-American Women.
    Borja-Hart N; Graff JC; Nolan VG; Wang J; Cooper-DeHoff RM; Ancheta IB
    J Clin Pharm Ther; 2019 Aug; 44(4):632-639. PubMed ID: 30963623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.